Diagnosis and Risk Factors of Prediabetes and Diabetes in People Living With Human Immunodeficiency Virus: Evaluation of Clinical and Microbiome Parameters
O Ziv(Israel Defense Forces Medical Corps), Hila Elinav(Hebrew University of Jerusalem), Jacob Strahilevitz(Hebrew University of Jerusalem), Yonatan Oster(Hadassah Medical Center), Tallulah Jansen(American Committee for the Weizmann Institute of Science), Valery Istomin, Itzchak Levy(Sheba Medical Center), Valeria Ivanova(American Committee for the Weizmann Institute of Science), Maya Korem(Hadassah Medical Center), Karen Olshtain‐Pops(Hebrew University of Jerusalem), Avivit Cahn(Hebrew University of Jerusalem), Rafael Valdés‐Mas(Weizmann Institute of Science), Eynat Kedem(Rambam Health Care Campus), Eran Elinav(German Cancer Research Center), Eduardo Shahar(Rambam Health Care Campus), Sarah Israel(Hadassah Medical Center), Efrat Orenbuch‐Harroch(Hebrew University of Jerusalem)
Cited by 2
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Interaction between microbiota and immunity in health and disease
|Cell Research|2020|3.8k
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
|Nature Medicine|2005|1k
Inflammasome activation and regulation: toward a better understanding of complex mechanisms
|Cell Discovery|2020|982